NASDAQ:BTSG - Nasdaq - US10950A1060 - Common Stock - Currency: USD
Overall BTSG gets a fundamental rating of 4 out of 10. We evaluated BTSG against 102 industry peers in the Health Care Providers & Services industry. While BTSG is still in line with the averages on profitability rating, there are concerns on its financial health. BTSG is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.98% | ||
ROE | 3.39% | ||
ROIC | 4.48% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 2.15% | ||
PM (TTM) | 0.49% | ||
GM | 13.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.48 | ||
Debt/FCF | 19.98 | ||
Altman-Z | 2.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.73 | ||
Quick Ratio | 1.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 34.39 | ||
Fwd PE | 21.71 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 29.14 | ||
EV/EBITDA | 13.85 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
21.32
+0.14 (+0.66%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 34.39 | ||
Fwd PE | 21.71 | ||
P/S | 0.32 | ||
P/FCF | 29.14 | ||
P/OCF | 18.19 | ||
P/B | 2.2 | ||
P/tB | N/A | ||
EV/EBITDA | 13.85 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.98% | ||
ROE | 3.39% | ||
ROCE | 5.67% | ||
ROIC | 4.48% | ||
ROICexc | 4.54% | ||
ROICexgc | 14.07% | ||
OM | 2.15% | ||
PM (TTM) | 0.49% | ||
GM | 13.46% | ||
FCFM | 1.1% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.48 | ||
Debt/FCF | 19.98 | ||
Debt/EBITDA | 5.59 | ||
Cap/Depr | 38.81% | ||
Cap/Sales | 0.66% | ||
Interest Coverage | 1.22 | ||
Cash Conversion | 45.71% | ||
Profit Quality | 222.79% | ||
Current Ratio | 1.73 | ||
Quick Ratio | 1.37 | ||
Altman-Z | 2.83 |